「Systematic review and Meta-analysis」の版間の差分

提供: Vaccipedia | Resources for Vaccines, Tropical medicine and Travel medicine
ナビゲーションに移動 検索に移動
 
(同じ利用者による、間の3版が非表示)
15行目: 15行目:
  
 
===weakness of MA===
 
===weakness of MA===
 +
 +
==conduct SR/MA==
 +
*no guidelines on the number of included studies in SR/MA
 +
*Cochrane has published SR/MA with only 1 study included
 +
 +
===optimal databases===
 +
Bramer WM, et al. Syst Rev. 2017 PMID:29208034
 +
*Medline/PubMed
 +
*Web of Science
 +
*Embase and/or Scopus
 +
**overlapping ratio between Embase and Scopus is very high
 +
*Google Scholar
 +
**grey literature
 +
as many as possible
 +
 +
*grey literatures
 +
**Google Scholar
 +
**New York Academy of Medicine Grey Literature Report
 +
**[[https://en.wikipedia.org/wiki/System_for_Information_on_Grey_Literature_in_Europe SIGLE]]
 +
 +
===data extraction===
 +
*most important and easily mistaken step

2021年4月26日 (月) 11:17時点における最新版

Systematic review

  • systematic review vs non-systematic review
  • every SR does not have a meta-analysis
    • such as Delphi method

strength of SR

weakness of SR

Meta-analysis

  • MA does not require SR

network meta-analysis

  • to compare efficacy of multiple treatment arms

strength of MA

  • overcome publication bias

weakness of MA

conduct SR/MA

  • no guidelines on the number of included studies in SR/MA
  • Cochrane has published SR/MA with only 1 study included

optimal databases

Bramer WM, et al. Syst Rev. 2017 PMID:29208034

  • Medline/PubMed
  • Web of Science
  • Embase and/or Scopus
    • overlapping ratio between Embase and Scopus is very high
  • Google Scholar
    • grey literature

as many as possible

  • grey literatures
    • Google Scholar
    • New York Academy of Medicine Grey Literature Report
    • [SIGLE]

data extraction

  • most important and easily mistaken step